Global Neurological Biomarker Market Research Report 2016


Report ID : RNR-11338 Category : Biotechnology Published Date : Sept 2016
Publisher : S&P Consulting Pages : 118 Format : PDF
Production, means the output of Neurological Biomarker
Revenue, means the sales value of Neurological Biomarker

This report studies Neurological Biomarker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Myriad RBM
    Proteome Sciences
    QIAGEN
    Thermo Fisher Scientific
    AbaStar MDx
    Abiant
    Acumen Pharmaceuticals
    Aepodia
    Alseres Pharmaceuticals
    Athena Diagnostics
    Banyan Biomarkers
    Cisbio Bioassays
    Diagenic
    Proteosys
    Psynova Neurotech
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neurological Biomarker in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by application, this report focuses on consumption, market share and growth rate of Neurological Biomarker in each application, can be divided into
    Application 1
    Application 2
    Application 3 
 Global Neurological Biomarker Market Research Report 2016
1 Neurological Biomarker Market Overview
    1.1 Product Overview and Scope of Neurological Biomarker
    1.2 Neurological Biomarker Segment by Type
        1.2.1 Global Production Market Share of Neurological Biomarker by Type in 2015
        1.2.2 Type I
        1.2.3 Type II
        1.2.4 Type III
    1.3 Neurological Biomarker Segment by Application
        1.3.1 Neurological Biomarker Consumption Market Share by Application in 2015
        1.3.2 Application 1
        1.3.3 Application 2
        1.3.4 Application 3
    1.4 Neurological Biomarker Market by Region
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 Europe Status and Prospect (2011-2021)
        1.4.3 China Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 Southeast Asia Status and Prospect (2011-2021)
        1.4.6 India Status and Prospect (2011-2021)
    1.5 Global Market Size (Value) of Neurological Biomarker (2011-2021)

2 Global Neurological Biomarker Market Competition by Manufacturers
    2.1 Global Neurological Biomarker Production and Share by Manufacturers (2015 and 2016)
    2.2 Global Neurological Biomarker Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global Neurological Biomarker Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers Neurological Biomarker Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Neurological Biomarker Market Competitive Situation and Trends
        2.5.1 Neurological Biomarker Market Concentration Rate
        2.5.2 Neurological Biomarker Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Neurological Biomarker Production, Revenue (Value) by Region (2011-2016)
    3.1 Global Neurological Biomarker Production by Region (2011-2016)
    3.2 Global Neurological Biomarker Production Market Share by Region (2011-2016)
    3.3 Global Neurological Biomarker Revenue (Value) and Market Share by Region (2011-2016)
    3.4 Global Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.5 North America Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.6 Europe Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.7 China Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.8 Japan Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.9 Southeast Asia Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
    3.10 India Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Neurological Biomarker Supply (Production), Consumption, Export, Import by Regions (2011-2016)
    4.1 Global Neurological Biomarker Consumption by Regions (2011-2016)
    4.2 North America Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
    4.3 Europe Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
    4.4 China Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
    4.5 Japan Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
    4.6 Southeast Asia Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
    4.7 India Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Neurological Biomarker Production, Revenue (Value), Price Trend by Type
    5.1 Global Neurological Biomarker Production and Market Share by Type (2011-2016)
    5.2 Global Neurological Biomarker Revenue and Market Share by Type (2011-2016)
    5.3 Global Neurological Biomarker Price by Type (2011-2016)
    5.4 Global Neurological Biomarker Production Growth by Type (2011-2016)

6 Global Neurological Biomarker Market Analysis by Application
    6.1 Global Neurological Biomarker Consumption and Market Share by Application (2011-2016)
    6.2 Global Neurological Biomarker Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Neurological Biomarker Manufacturers Profiles/Analysis
    7.1 Myriad RBM
        7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.1.2 Neurological Biomarker Product Type, Application and Specification
            7.1.2.1 Type I
            7.1.2.2 Type II
        7.1.3 Myriad RBM Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.1.4 Main Business/Business Overview
    7.2 Proteome Sciences
        7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.2.2 Neurological Biomarker Product Type, Application and Specification
            7.2.2.1 Type I
            7.2.2.2 Type II
        7.2.3 Proteome Sciences Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.2.4 Main Business/Business Overview
    7.3 QIAGEN
        7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.3.2 Neurological Biomarker Product Type, Application and Specification
            7.3.2.1 Type I
            7.3.2.2 Type II
        7.3.3 QIAGEN Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.3.4 Main Business/Business Overview
    7.4 Thermo Fisher Scientific
        7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.4.2 Neurological Biomarker Product Type, Application and Specification
            7.4.2.1 Type I
            7.4.2.2 Type II
        7.4.3 Thermo Fisher Scientific Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.4.4 Main Business/Business Overview
    7.5 AbaStar MDx
        7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.5.2 Neurological Biomarker Product Type, Application and Specification
            7.5.2.1 Type I
            7.5.2.2 Type II
        7.5.3 AbaStar MDx Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.5.4 Main Business/Business Overview
    7.6 Abiant
        7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.6.2 Neurological Biomarker Product Type, Application and Specification
            7.6.2.1 Type I
            7.6.2.2 Type II
        7.6.3 Abiant Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.6.4 Main Business/Business Overview
    7.7 Acumen Pharmaceuticals
        7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.7.2 Neurological Biomarker Product Type, Application and Specification
            7.7.2.1 Type I
            7.7.2.2 Type II
        7.7.3 Acumen Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.7.4 Main Business/Business Overview
    7.8 Aepodia
        7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.8.2 Neurological Biomarker Product Type, Application and Specification
            7.8.2.1 Type I
            7.8.2.2 Type II
        7.8.3 Aepodia Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.8.4 Main Business/Business Overview
    7.9 Alseres Pharmaceuticals
        7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.9.2 Neurological Biomarker Product Type, Application and Specification
            7.9.2.1 Type I
            7.9.2.2 Type II
        7.9.3 Alseres Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.9.4 Main Business/Business Overview
    7.10 Athena Diagnostics
        7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
        7.10.2 Neurological Biomarker Product Type, Application and Specification
            7.10.2.1 Type I
            7.10.2.2 Type II
        7.10.3 Athena Diagnostics Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
        7.10.4 Main Business/Business Overview
    7.11 Banyan Biomarkers
    7.12 Cisbio Bioassays
    7.13 Diagenic
    7.14 Proteosys
    7.15 Psynova Neurotech

8 Neurological Biomarker Manufacturing Cost Analysis
    8.1 Neurological Biomarker Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Neurological Biomarker

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Neurological Biomarker Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Neurological Biomarker Market Forecast (2016-2021)
    12.1 Global Neurological Biomarker Production, Revenue Forecast (2016-2021)
    12.2 Global Neurological Biomarker Production, Consumption Forecast by Regions (2016-2021)
    12.3 Global Neurological Biomarker Production Forecast by Type (2016-2021)
    12.4 Global Neurological Biomarker Consumption Forecast by Application (2016-2021)
    12.5 Neurological Biomarker Price Forecast (2016-2021)

13 Research Findings and Conclusion